$CDZI
CADIZ INC

2020 Q4 Form 10-Q Financial Statement

#000143774920022803 Filed on November 05, 2020

View on sec.gov

Income Statement

Concept 2020 Q4 2020 Q3 2019 Q3
Revenue $140.0K $139.0K $110.0K
YoY Change 26.13% 26.36% -1.79%
Cost Of Revenue
YoY Change
Gross Profit $110.0K
YoY Change -1.79%
Gross Profit Margin 100.0%
Selling, General & Admin $2.310M $2.530M $3.000M
YoY Change -21.96% -15.67% 18.11%
% of Gross Profit 2727.27%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $100.0K $100.0K $70.00K
YoY Change 42.86% 42.86% 16.67%
% of Gross Profit 63.64%
Operating Expenses $2.410M $2.630M $3.070M
YoY Change -20.2% -14.33% 18.08%
Operating Profit -$2.494M -$2.956M
YoY Change -15.63% 18.81%
Interest Expense -$4.350M $1.920M $4.369M
YoY Change 5.33% -56.05% 14.1%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$6.620M -$4.414M -$7.258M
YoY Change -5.97% -39.18% 16.31%
Income Tax $0.00 $2.000K $1.000K
% Of Pretax Income
Net Earnings -$8.020M -$4.493M -$7.444M
YoY Change 9.12% -39.64% 19.29%
Net Earnings / Revenue -5728.57% -3232.37% -6767.27%
Basic Earnings Per Share
Diluted Earnings Per Share -$253.5K -$128.1K -$275.9K
COMMON SHARES
Basic Shares Outstanding 35.54M 34.80M
Diluted Shares Outstanding 35.04K 26.97K

Balance Sheet

Concept 2020 Q4 2020 Q3 2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $7.300M $7.500M $15.30M
YoY Change -53.5% -50.98% -13.56%
Cash & Equivalents $7.290M $7.502M $15.27M
Short-Term Investments
Other Short-Term Assets $700.0K $600.0K $500.0K
YoY Change 75.0% 20.0% 0.0%
Inventory
Prepaid Expenses
Receivables $55.00K $96.00K $93.00K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $8.036M $8.233M $15.89M
YoY Change -50.14% -48.18% -13.22%
LONG-TERM ASSETS
Property, Plant & Equipment $53.48M $52.68M $47.59M
YoY Change 7.08% 10.7% 2.78%
Goodwill $3.813M $3.813M $3.813M
YoY Change 0.0% 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments $1.354M $2.347M $71.00K
YoY Change 85.73% 3205.63%
Other Assets $4.530M $4.299M $4.157M
YoY Change 10.0% 3.42% 6.56%
Total Long-Term Assets $66.33M $65.14M $57.63M
YoY Change 9.44% 13.03% 6.69%
TOTAL ASSETS
Total Short-Term Assets $8.036M $8.233M $15.89M
Total Long-Term Assets $66.33M $65.14M $57.63M
Total Assets $74.36M $73.37M $73.52M
YoY Change -3.08% -0.2% 1.65%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $548.0K $438.0K $666.0K
YoY Change 182.47% -34.23% -38.67%
Accrued Expenses $674.0K $863.0K $927.0K
YoY Change -85.14% -6.9% 4.27%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $51.00K $54.00K $42.00K
YoY Change 64.52% 28.57% -27.59%
Total Short-Term Liabilities $3.135M $3.108M $2.601M
YoY Change -34.76% 19.49% -17.48%
LONG-TERM LIABILITIES
Long-Term Debt $78.60M $75.23M $141.4M
YoY Change -42.87% -46.8% 6.09%
Other Long-Term Liabilities $0.00 $0.00 $26.00K
YoY Change -100.0% -100.0% -98.47%
Total Long-Term Liabilities $78.60M $75.23M $141.4M
YoY Change -42.87% -46.81% 6.11%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.135M $3.108M $2.601M
Total Long-Term Liabilities $78.60M $75.23M $141.4M
Total Liabilities $99.66M $95.89M $160.2M
YoY Change -37.26% -40.13% 5.21%
SHAREHOLDERS EQUITY
Retained Earnings -$539.4M -$531.4M -$494.2M
YoY Change 7.54% 7.52% 6.98%
Common Stock $368.0K $353.0K $270.0K
YoY Change 29.12% 30.74% 10.2%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$25.30M -$22.52M -$86.64M
YoY Change
Total Liabilities & Shareholders Equity $74.36M $73.37M $73.52M
YoY Change -3.08% -0.2% 1.65%

Cashflow Statement

Concept 2020 Q4 2020 Q3 2019 Q3
OPERATING ACTIVITIES
Net Income -$8.020M -$4.493M -$7.444M
YoY Change 9.12% -39.64% 19.29%
Depreciation, Depletion And Amortization $100.0K $100.0K $70.00K
YoY Change 42.86% 42.86% 16.67%
Cash From Operating Activities -$3.130M -$3.280M -$3.830M
YoY Change 3.99% -14.36% 72.52%
INVESTING ACTIVITIES
Capital Expenditures -$630.0K -$390.0K -$610.0K
YoY Change 270.59% -36.07% 84.85%
Acquisitions
YoY Change
Other Investing Activities -$1.400M -$430.0K
YoY Change 55.56%
Cash From Investing Activities -$2.030M -$810.0K -$610.0K
YoY Change 89.72% 32.79% 84.85%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 4.940M 6.030M 240.0K
YoY Change 10.02% 2412.5% -2500.0%
NET CHANGE
Cash From Operating Activities -3.130M -3.280M -3.830M
Cash From Investing Activities -2.030M -810.0K -610.0K
Cash From Financing Activities 4.940M 6.030M 240.0K
Net Change In Cash -220.0K 1.940M -4.200M
YoY Change -153.66% -146.19% 64.06%
FREE CASH FLOW
Cash From Operating Activities -$3.130M -$3.280M -$3.830M
Capital Expenditures -$630.0K -$390.0K -$610.0K
Free Cash Flow -$2.500M -$2.890M -$3.220M
YoY Change -11.97% -10.25% 70.37%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
10000
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
35544100
CY2020Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000
CY2020Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
10000
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
70000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
70000000
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
35401834
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
35401834
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28480567
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28480567
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2020Q3 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
0 USD
CY2020Q3 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2020Q3 us-gaap Revenues
Revenues
139000 USD
CY2019Q3 us-gaap Revenues
Revenues
110000 USD
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2527000 USD
CY2019Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2998000 USD
CY2020Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
106000 USD
CY2019Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
68000 USD
CY2020Q3 us-gaap Costs And Expenses
CostsAndExpenses
2633000 USD
CY2019Q3 us-gaap Costs And Expenses
CostsAndExpenses
3066000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2494000 USD
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2956000 USD
CY2020Q3 us-gaap Interest Expense
InterestExpense
1920000 USD
CY2019Q3 us-gaap Interest Expense
InterestExpense
4369000 USD
CY2020Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
0 USD
CY2019Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
67000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-4414000 USD
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-7258000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2000 USD
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1000 USD
CY2020Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-77000 USD
CY2019Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-185000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-4493000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-7444000 USD
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.13
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.28
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35036
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26970
us-gaap Revenues
Revenues
401000 USD
us-gaap Revenues
Revenues
330000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9602000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9207000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
281000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
200000 USD
us-gaap Costs And Expenses
CostsAndExpenses
9883000 USD
us-gaap Costs And Expenses
CostsAndExpenses
9407000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-9482000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-9077000 USD
us-gaap Interest Expense
InterestExpense
7166000 USD
us-gaap Interest Expense
InterestExpense
12906000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
23000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
189000 USD
us-gaap Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
-0 USD
us-gaap Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
197000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-12394000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-29019000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-21991000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-776000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-185000 USD
us-gaap Net Income Loss
NetIncomeLoss
-29800000 USD
us-gaap Net Income Loss
NetIncomeLoss
-22180000 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.89
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.85
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33654
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26265
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7502000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15682000 USD
CY2020Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
96000 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
49000 USD
CY2020Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
635000 USD
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
386000 USD
CY2020Q3 us-gaap Assets Current
AssetsCurrent
8233000 USD
CY2019Q4 us-gaap Assets Current
AssetsCurrent
16117000 USD
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
52682000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
49947000 USD
CY2020Q3 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
2000000 USD
CY2019Q4 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
2000000 USD
CY2020Q3 us-gaap Equity Method Investments
EquityMethodInvestments
2347000 USD
CY2019Q4 us-gaap Equity Method Investments
EquityMethodInvestments
729000 USD
CY2020Q3 us-gaap Goodwill
Goodwill
3813000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
3813000 USD
CY2020Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4299000 USD
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4118000 USD
CY2020Q3 us-gaap Assets
Assets
73374000 USD
CY2019Q4 us-gaap Assets
Assets
76724000 USD
CY2020Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
438000 USD
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
194000 USD
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
863000 USD
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4536000 USD
CY2020Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
54000 USD
CY2019Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
31000 USD
CY2020Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
1727000 USD
CY2019Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
0 USD
CY2020Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
26000 USD
CY2019Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
44000 USD
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
3108000 USD
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4805000 USD
CY2020Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
75225000 USD
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
137565000 USD
CY2020Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
16807000 USD
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
15707000 USD
CY2020Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
750000 USD
CY2019Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
750000 USD
CY2020Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
0 USD
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
15000 USD
CY2020Q3 us-gaap Liabilities
Liabilities
95890000 USD
CY2019Q4 us-gaap Liabilities
Liabilities
158842000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
200000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
823000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
3062000 USD
cdzi Paid In Kind Interest Added To Loan Principal
PaidInKindInterestAddedToLoanPrincipal
4120000 USD
cdzi Paid In Kind Interest Added To Loan Principal
PaidInKindInterestAddedToLoanPrincipal
7523000 USD
cdzi Paid In Kind Interest Added To Lease Liability
PaidInKindInterestAddedToLeaseLiability
1082000 USD
cdzi Paid In Kind Interest Added To Lease Liability
PaidInKindInterestAddedToLeaseLiability
947000 USD
cdzi Income Loss From Equity Method Investments Excluding Investing Activities
IncomeLossFromEquityMethodInvestmentsExcludingInvestingActivities
-776000 USD
cdzi Income Loss From Equity Method Investments Excluding Investing Activities
IncomeLossFromEquityMethodInvestmentsExcludingInvestingActivities
-0 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-82118000 USD
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
73374000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
76724000 USD
us-gaap Net Income Loss
NetIncomeLoss
-29800000 USD
us-gaap Net Income Loss
NetIncomeLoss
-22180000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
281000 USD
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
353000 USD
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
285000 USD
CY2020Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
508527000 USD
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
419194000 USD
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-531397000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-501597000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-22516000 USD
CY2020Q3 us-gaap Preferred Stock Value
PreferredStockValue
1000 USD
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
cdzi Gains Losses On Debt Conversion And Extinguishment Of Debt
GainsLossesOnDebtConversionAndExtinguishmentOfDebt
-12394000 USD
cdzi Gains Losses On Debt Conversion And Extinguishment Of Debt
GainsLossesOnDebtConversionAndExtinguishmentOfDebt
-38000 USD
us-gaap Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
0 USD
us-gaap Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
197000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1824000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
410000 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-259000 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
47000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
55000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
249000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
115000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
214000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
215000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
226000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
405000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1253000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-921000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-10296000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-10704000 USD
us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
2709000 USD
us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
-0 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5103000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1428000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7812000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1428000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
9808000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
14890000 USD
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
150000 USD
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
0 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
30000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
44000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
9928000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
14846000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-8180000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2714000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
15816000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
12691000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7636000 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
15405000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-82118000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
38900000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1251000 USD
CY2020Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3923000 USD
CY2020Q1 cdzi Current Period Reclassification Adjustment
CurrentPeriodReclassificationAdjustment
-865000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-20514000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-19687000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
300000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-4793000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-24180000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
273000 USD
CY2020Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
5884000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-4493000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-22516000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-86240000 USD
CY2019Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
3204000 USD
CY2019Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
122000 USD
CY2019Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
7891000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-7260000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
-81418000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
2251000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
123000 USD
CY2019Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
6752000 USD
CY2019Q2 us-gaap Warrant Down Round Feature Increase Decrease In Equity Amount
WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount
0 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-7476000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
-79768000 USD
CY2019Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
157000 USD
CY2019Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
165000 USD
CY2019Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
247000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-7444000 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
-86643000 USD
us-gaap Net Income Loss
NetIncomeLoss
-29800000 USD
us-gaap Net Income Loss
NetIncomeLoss
-22200000 USD
CY2020Q3 cdzi Working Capital
WorkingCapital
5100000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-10300000 USD
CY2020Q1 cdzi Required Payment To Acquire Property Available For Purchase Due End Of Fiscal Year
RequiredPaymentToAcquirePropertyAvailableForPurchaseDueEndOfFiscalYear
19000000 USD
CY2020Q3 cdzi Percentage Of Future Quarterly Interest Payments
PercentageOfFutureQuarterlyInterestPayments
0.25 pure
us-gaap Interest Paid Net
InterestPaidNet
1100000 USD
us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
38900000 USD
us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
5766337
CY2020Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
27300000 USD
CY2020Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
10000
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7502000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15682000 USD
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15272000 USD
CY2020Q3 us-gaap Restricted Cash
RestrictedCash
134000 USD
CY2019Q4 us-gaap Restricted Cash
RestrictedCash
134000 USD
CY2019Q3 us-gaap Restricted Cash
RestrictedCash
133000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7636000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
15816000 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
15405000 USD
CY2020Q1 cdzi Debt Instrument Prepayment Premium Percent
DebtInstrumentPrepaymentPremiumPercent
0.07 pure
CY2020Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.01
CY2020Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
2000000.0 USD
CY2020Q1 cdzi Reclassification Of Warrant Liability To Additional Paidin Capital
ReclassificationOfWarrantLiabilityToAdditionalPaidinCapital
900000 USD
CY2020Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
1100000 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-259000 USD
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
115000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1824000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
410000 USD
CY2020Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1500000 USD
CY2020Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4525000
CY2019Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11288000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3528000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11469000
CY2020Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
865000 USD
CY2020Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
1100000 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-259000 USD
CY2020Q3 us-gaap Derivative Liabilities
DerivativeLiabilities
1727000 USD
CY2020Q3 us-gaap Financial Liabilities Fair Value Disclosure
FinancialLiabilitiesFairValueDisclosure
1727000 USD

Files In Submission

Name View Source Status
0001437749-20-022803-index-headers.html Edgar Link pending
0001437749-20-022803-index.html Edgar Link pending
0001437749-20-022803.txt Edgar Link pending
0001437749-20-022803-xbrl.zip Edgar Link pending
cdzi-20200930.xsd Edgar Link pending
cdzi-20200930_cal.xml Edgar Link unprocessable
cdzi-20200930_def.xml Edgar Link unprocessable
cdzi-20200930_lab.xml Edgar Link unprocessable
cdzi-20200930_pre.xml Edgar Link unprocessable
cdzi20200930c_10q.htm Edgar Link pending
cdzi20200930c_10q_htm.xml Edgar Link completed
ex_210630.htm Edgar Link pending
ex_210631.htm Edgar Link pending
ex_210632.htm Edgar Link pending
ex_210633.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending